Hyperprogressive disease after avelumab maintenance therapy in a patient with advanced ureter cancer: A case report.

Ogasawara, Keita; Ikarashi, Daiki; Tamada, Shinji; Tsuyukubo, Takashi; Fujisawa, Hiromitsu; Obara, Wataru.

Afiliação

Ogasawara K; Department of Urology, Iwate Prefectural Central Hospital 4-1, Ueda, Morioka-shi, Iwate, 020-0066, Japan.
Ikarashi D; Department of Urology, Iwate Prefectural Central Hospital 4-1, Ueda, Morioka-shi, Iwate, 020-0066, Japan.
Tamada S; Department of Urology, Iwate Medical University School of Medicine, 2-1-1, Yahaba, Shiwa-gun, Iwate, 028-3695, Japan.
Tsuyukubo T; Department of Urology, Iwate Prefectural Central Hospital 4-1, Ueda, Morioka-shi, Iwate, 020-0066, Japan.
Fujisawa H; Department of Urology, Iwate Prefectural Central Hospital 4-1, Ueda, Morioka-shi, Iwate, 020-0066, Japan.
Obara W; Department of Urology, Iwate Prefectural Central Hospital 4-1, Ueda, Morioka-shi, Iwate, 020-0066, Japan.

Urol Case Rep ; 45: 102278, 2022 Nov.

Article em En | MEDLINE | ID: mdl-36425905